Psivant Therapeutics
Psivant Therapeutics is advancing a paradigm shift in biotechnology by pioneering a physics-driven approach to drug design that is tightly coupled to chemistry and biology research and development. Our QUAISAR platform is purpose-built to develop novel small molecule therapeutics to address biologically and genetically validated, but previously intractable, protein targets.
Work at Psivant Therapeutics in HR or recruiting? Claim this page
Headcount trend
Psivant Therapeutics went from 24 employees in Mar 2023 to 27 in Feb 2025. Sep 2024 to Feb 2025: 5 people joined, 1 left.
Headcount data through Feb 2025
Org structure
Headcount by department
H-1B sponsorship
Peer reviews
Worked with someone at Psivant Therapeutics?
Anonymous peer reviews on OffTheRecord
Hiring now
Similar companies
Psivant Therapeutics FAQ
How many employees does Psivant Therapeutics have?
Psivant Therapeutics has about 27 employees, unchanged over the 3 months to Feb 2025.
Does Psivant Therapeutics sponsor H1B visas?
Yes. Psivant Therapeutics filed 3 H1B (LCA) applications in FY2026, according to the latest U.S. Department of Labor disclosures. Most of them were for Engineering roles.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.